BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 19 filers reported holding BELLEROPHON THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $230,000 | -88.5% | 659,087 | -84.1% | 0.06% | -92.0% |
| Q3 2019 | $2,000,000 | -19.7% | 4,149,378 | 0.0% | 0.76% | -2.9% |
| Q2 2019 | $2,490,000 | -8.1% | 4,149,378 | 0.0% | 0.78% | -1.0% |
| Q1 2019 | $2,710,000 | -18.5% | 4,149,378 | 0.0% | 0.79% | -44.4% |
| Q4 2018 | $3,325,000 | -25.8% | 4,149,378 | 0.0% | 1.43% | +19.2% |
| Q3 2018 | $4,481,000 | -55.4% | 4,149,378 | 0.0% | 1.20% | -60.2% |
| Q2 2018 | $10,041,000 | +16.3% | 4,149,378 | 0.0% | 3.01% | +44.3% |
| Q1 2018 | $8,631,000 | -10.8% | 4,149,378 | 0.0% | 2.08% | -10.1% |
| Q4 2017 | $9,671,000 | +104.9% | 4,149,378 | 0.0% | 2.32% | +77.8% |
| Q3 2017 | $4,720,000 | – | 4,149,378 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLINSKY STEVEN B | 4,859,885 | $44,614,000 | 20.33% |
| Senator Investment Group LP | 448,679 | $4,119,000 | 0.04% |
| HIGHLAND CAPITAL MANAGEMENT LP | 162,177 | $1,489,000 | 0.03% |
| Baker Brothers Advisors | 350,000 | $3,213,000 | 0.03% |
| Alyeska Investment Group, L.P. | 94,131 | $864,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 30,000 | $275,000 | 0.01% |
| FMR LLC | 1,302,070 | $11,953,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 15,427 | $142,000 | 0.00% |
| BlackRock Investment Management, LLC | 846 | $8,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 17,290 | $159,000 | 0.00% |